Halyard Health Inc (NYSE:HYH) had its price objective dropped by equities research analysts at JMP Securities from $40.00 to $32.00 in a report released on Wednesday, AnalystRatings.Net reports. The firm presently has a “buy” rating on the stock. JMP Securities’ price objective indicates a potential upside of 29.03% from the company’s previous close.

Halyard Health (NYSE:HYH) traded up 2.86% during midday trading on Wednesday, hitting $24.80. 537,129 shares of the stock traded hands. Halyard Health has a one year low of $22.87 and a one year high of $50.92. The stock’s market cap is $1.16 billion. The company has a 50-day moving average price of $29.56 and a 200 day moving average price of $31.74.

Halyard Health (NYSE:HYH) last announced its earnings results on Tuesday, November 3rd. The company reported $0.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.05. The company earned $390 million during the quarter, compared to the consensus estimate of $388 million. The company’s revenue was down 4.5% on a year-over-year basis. Equities research analysts anticipate that Halyard Health will post $2.05 earnings per share for the current year.

Other institutional investors have recently bought and sold shares of the company. Cambiar Investors LLC purchased a new position in Halyard Health during the fourth quarter valued at $25,026,000. Lombardia Capital Partners LLC raised its stake in Halyard Health by 729.2% in the fourth quarter. Lombardia Capital Partners LLC now owns 581,605 shares of the company’s stock worth $19,431,000 after buying an additional 511,463 shares during the last quarter. Louisiana State Employees Retirement System acquired a new stake in Halyard Health during the fourth quarter worth about $431,000. Fox Run Management acquired a new stake in Halyard Health during the fourth quarter worth about $378,000. Finally, California State Teachers Retirement System boosted its stake in shares of Halyard Health by 1.5% in the fourth quarter. California State Teachers Retirement System now owns 86,197 shares of the company’s stock valued at $2,880,000 after buying an additional 1,305 shares during the period.

A number of other brokerages also recently weighed in on HYH. Stifel Nicolaus began coverage on shares of Halyard Health in a report on Wednesday, December 2nd. They issued a “buy” rating and a $38.00 price target for the company. They noted that the move was a valuation call. Morgan Stanley downgraded shares of Halyard Health from an “equal weight” rating to an “underweight” rating and set a $27.00 price target for the company. in a report on Monday, October 12th. KeyBanc began coverage on shares of Halyard Health in a report on Friday, December 18th. They issued a “sector weight” rating for the company. Finally, Zacks Investment Research raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Thursday, November 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. Halyard Health currently has a consensus rating of “Hold” and a consensus price target of $32.25.

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (NYSE:HYH) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings, including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes, focused on pain management and respiratory and digestive health.

12 Month Chart for NYSE:HYH

Receive News & Ratings for Halyard Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.